These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 7522113)
1. Combined modality treatment for locally advanced non-small cell lung cancer--which control arm? Johnson DH Lung Cancer; 1994 Mar; 10 Suppl 1():S231-8. PubMed ID: 7522113 [TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy of non-small cell lung cancers. Juretic A; Sobat H; Samija M Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559 [TBL] [Abstract][Full Text] [Related]
3. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Crinò L; Latini P; Meacci M; Corgna E; Maranzano E; Darwish S; Minotti V; Santucci A; Tonato M Ann Oncol; 1993 Dec; 4(10):847-51. PubMed ID: 8117604 [TBL] [Abstract][Full Text] [Related]
5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
6. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer]. Kubota K Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912 [TBL] [Abstract][Full Text] [Related]
10. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Pritchard RS; Anthony SP Ann Intern Med; 1996 Nov; 125(9):723-9. PubMed ID: 8929005 [TBL] [Abstract][Full Text] [Related]
12. Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601. Sugawara S; Maemondo M; Tachihara M; Inoue A; Ishimoto O; Sakakibara T; Usui K; Watanabe H; Matsubara N; Watanabe K; Kanazawa K; Ishida T; Saijo Y; Nukiwa T; Lung Cancer; 2013 Jul; 81(1):91-6. PubMed ID: 23643176 [TBL] [Abstract][Full Text] [Related]
13. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer]. Kawahara M Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104 [TBL] [Abstract][Full Text] [Related]
14. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194 [TBL] [Abstract][Full Text] [Related]